Decreased gray matter diffusivity: A potential early Alzheimer's disease biomarker?
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Background: Gray matter atrophy, an important biomarker for early Alzheimer's disease, might be due to white matter changes within gray matter. Methods: Twenty older participants with significant memory decline over a 12‐year period (T12) were matched to 20 nondeclining participants. All participants were magnetic resonance imaging scanned at T12. Cortical thickness and diffusion tensor imaging analyses were performed. Results: Lower cortical thickness values were associated with lower diffusion values in frontal and parietal gray matter areas. This association was only present in the memory decline group. The cortical thickness–diffusion tensor imaging correlations showed significant group differences in the posterior cingulate gyrus, precuneus, and superior frontal gyrus. Conclusions: Decreased gray matter diffusivity in the posterior cingulate/precuneus area might be a disease‐specific process and a potential new biomarker for early Alzheimer's disease. Future studies should validate its potential as a biomarker and focus on cellular changes underlying diffusivity changes in gray matter.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Revising the definition of Alzheimer's disease: a new lexicon
Dubois, B., Feldman, H. H., Jacova, C., Cummings, J. L., DeKosky, S. T., Barberger-Gateau, P., Delacourte, A., Frisoni, G., Fox, N. C., Galasko, D., et al. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70223-4 · Cited by 1,869 · cited 5×
“Advances in neuroimaging have provided new in vivo biomarkers, such as amyloid accumulation (positron emission tomography), posterior hypoperfusion (single-photon emission computed tomography) or hypometabolism (positron emission tomography), temporoparietal atrophy (magnetic resonance imaging [MRI]), and distinct tau…”
BackgroundInfluentialAbout “axial” and “radial” diffusivities
Wheeler‐Kingshott, C. A. M., & Cercignani, M. (2009) · Magnetic Resonance in Medicine · doi:10.1002/mrm.21965 · Cited by 885
Head, D. (2004) · Cerebral Cortex · doi:10.1093/cercor/bhh003 · Cited by 645
Absolute diffusivities define the landscape of white matter degeneration in Alzheimer’s disease
Acosta-Cabronero, J., Williams, G. B., Pengas, G., & Nestor, P. J. (2010) · Brain · doi:10.1093/brain/awp257 · Cited by 393 · cited 10×
“DTI images result from the diffusion of water molecules along fiber tracts in a local (voxel)-specific frame and enable the investigation of white matter tract alterations during development, aging, and disorders.”
BackgroundInfluentialMild cognitive impairment and Alzheimer disease: regional diffusivity of water
Kantarci, K., Jack, C. R., Xu, Y. C., Campeau, N. G., O’Brien, P. C., Smith, G. E., Ivnik, R. J., Boeve, B. F., Kokmen, E., Tangalos, E. G., et al. (2001) · Radiology · doi:10.1148/radiology.219.1.r01ap14101 · Cited by 300 · cited 1×
“Nonetheless, diffusivity changes within gray matter may be due to degenerative changes in myelin and axons in gyral cores and subarcuate fibers in the gray matter, resulting from neuron loss, reduced synaptic density, or reduced metabolic activity [20].”
BackgroundJacobs, H. I. L., Van Boxtel, M. P. J., Jolles, J., Verhey, F. R. J., & Uylings, H. B. M. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2011.06.009 · Cited by 293
Self-citationRabin, L. A., Paré, N., Saykin, A. J., Brown, M. J., Wishart, H. A., Flashman, L. A., & Santulli, R. B. (2009) · Aging, Neuropsychology, and Cognition · doi:10.1080/13825580902825220 · Cited by 256
Villain, N., Fouquet, M., Baron, J.-C., Mezenge, F., Landeau, B., de La Sayette, V., Viader, F., Eustache, F., Desgranges, B., & Chetelat, G. (2010) · Brain · doi:10.1093/brain/awq203 · Cited by 237
Cited by
Weston, P. S. J., Simpson, I. J. A., Ryan, N. S., Ourselin, S., & Fox, N. C. (2015) · Alzheimer's Research & Therapy · doi:10.1186/s13195-015-0132-3 · Cited by 214
“One study [36] of 20 patients with amnestic MCI found elevated diffusivity (with associated reduced fractional anisotropy) compared with controls, in a cortical distribution very similar to that described above.”
ResultInfluentialCortical microstructural changes along the Alzheimer’s disease continuum
Montal, V., Vilaplana, E., Alcolea, D., Pegueroles, J., Pasternak, O., González‐Ortiz, S., Clarimón, J., Carmona‐Iragui, M., Illán‐Gala, I., Morenas‐Rodríguez, E., et al. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2017.09.013 · Cited by 204
Parker, T. D., Slattery, C. F., Zhang, J., Nicholas, J. M., Paterson, R. W., Foulkes, A. J. M., Malone, I. B., Thomas, D. L., Modat, M., Cash, D. M., et al. (2018) · Human Brain Mapping · doi:10.1002/hbm.24056 · Cited by 122
“…clinically established AD (Rose, Janke PhD, & Chalk, 2008), conversion to AD from mild cognitive impairment (Scola et al., 2010), cognitive decline (Jacobs et al., 2013), cerebrospinal fluid (CSF) biomarkers of AD pathology in cognitively normal individuals (Montal et al., 2017), and have been…”
BackgroundFunctional craniology and brain evolution: from paleontology to biomedicine
Bruner, E., de la Cuétara, J. M., Masters, M., Amano, H., & Ogihara, N. (2014) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2014.00019 · Cited by 87
“More recently however, it has been shown that in the earliest stages of the disease, metabolic impairments, neuroanatomical, and histological changes, can be found in the medial parietal cortex (Jacobs et al., 2012, 2013; Doré et al., 2013; Huang et al., 2013).”
BackgroundWang, W.-E., Chen, R., Mayrand, R. P., Adjouadi, M., Fang, R., DeKosky, S. T., Duara, R., Coombes, S. A., & Vaillancourt, D. E. (2023) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2022.10.013 · Cited by 20
Metadata
- Authors
- Jacobs, H. I. L., van Boxtel, M. P. J., Gronenschild, E. H. B. M., Uylings, H. B. M., Jolles, J., & Verhey, F. R. J.
- Venue
- Alzheimer's & Dementia
- Publisher
- Wiley
- Published
- 2012-06-04
- Volume
- 9
- Issue
- 1
- Pages
- 93-97
- ISSN
- 1552-5260 (ISSN-L)
- 1552-5279
- OpenAlex
- W2127905892
- Cited by
- 39
- References
- 8
- FWCI
- 2.25
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Decreased gray matter diffusivity: A potential early Alzheimer's disease biomarker? https://app.cochat.ai/papers/10.1016/j.jalz.2011.11.004
- The paper
- Jacobs, H. I. L., van Boxtel, M. P. J., Gronenschild, E. H. B. M., Uylings, H. B. M., Jolles, J., & Verhey, F. R. J. (2013). Decreased gray matter diffusivity: A potential early Alzheimer's disease biomarker? Alzheimer's & Dementia. https://doi.org/10.1016/j.jalz.2011.11.004
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.